Bexsero vaccine

Learn about meningitis B and the benefits and safety information of BEXSERO. Tell your vaccine provider if the person getting the vaccine : Has had an allergic reaction after a previous dose of meningococcal B vaccine , or has any severe, life-threatening allergies. Adolescents are at increased risk for meningococcal disease.

Anyone can get meningococcal disease. However, adolescents and young adults through years of age are at increased risk for meningococcal disease.

Prescribing Information for BEXSERO. Wang X, Cohn A, Comanducci M, et al. Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis. Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-13 and Y. The vaccines are between and 1 effective for at least two years. Learn more about the possible side effects as well as other important safety information.

Administer doses (-mL each) of BEXSERO at least month apart. Shake the syringe immediately before use to form a homogeneous suspension. Federal government websites often end in.

BEXSERO multicomponent meningococcal B vaccine (recombinant, adsorbed) is a vaccine for the prevention of meningococcal disease caused by Neisseria meningitidis group B bacteria in individuals from months through years of age. Public Health Division. This questions and sheet for health care professionals provides basic information only.

Before taking this medicine. You should not receive this vaccine if you have ever had an allergic reaction to Bexsero. Includes common and rare side effects information for consumers and healthcare professionals.

BEXSERO is approved for use in individuals through years of age. Search for jobs and graduate positions across the world of GSK. Bexsero vaccine GSK Meningococcal group B Vaccine. The MenB vaccine is recommended for babies aged weeks, weeks and year as part of the NHS routine childhood vaccination programme.

The MenB vaccine will protect your baby against infection by meningococcal group B bacteria, which are responsible for more than of meningococcal infections in young children. It’s the first and only meningitis B vaccine that can be used in children under years of age.

Read all vaccine information available from your health care professional before receiving the vaccine. If you have any questions, ask your health care professional. The FDA is announcing the approval of Trumenba, the first vaccine approved in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in. CVX codes indicate the product used in a vaccination.

MVX codes indicate the manufacturer of a vaccine. The combination of proteins was chosen to protect against the majority of MenB strains. Questions and (QAs) about meningococcal B vaccine from immunization experts at the Centers for Disease Control and Prevention (CDC).